Lockdown doesn’t need to mean the end of networking. Connection is a vital part of business, and for clinical trials it can mean the difference between success and failure. At Siron Clinical, we know how important it is to maintain connections and make new ones, so...
An estimated 1.2 million children and teenagers across the United States are allergic to peanuts – that accounts for around 1 in 50 children. This pattern is seen globally, making peanut allergy the second most common food allergy after egg. Now, for the first time,...
Siron Clinical’s CEO, Jan Balemans, will attend BIO-Europe Spring 2020 from March 23 – 27. BIO-Europe attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize...
For the past 20 years, Siron Clinical has provided a high level of expertise in clinical trials for small and medium-sized biotechs who are navigating European clinical research. We have built a name and reputation as an experienced CRO. Our no-nonsense approach,...
